To create the society without people left behind

In an aging society with a declining birthrate, it is important not only to extend healthy life expectancy, but also to maintain the number of healthy children. We try to solve the problems of both pediatric and aging diseases.

Transforming Eye Care by Solving Unmet Medical Needs

FELIQS【fíːlɪks】is a clinical-stage ophthalmology company, dedicated to developing innovative therapies that redefine neonatal ophthalmology care through science that protects sight from the very beginning of life. Anchored in translational science and patient-centered design, FELIQS integrates academic collaboration, regulatory expertise, and cross-border innovation between Japan and the United States to advance the programs.

The company’s mission - “Every Life Deserves to See” - reflects its commitment to restoring vision and improving the quality of life for the most vulnerable patients. FELIQS operates through its U.S. entity, FELIQS Inc., and is conducting the phase 1b clinical studies in the US for FLQ-101.

FELIQS EXPANDED ACCESS POLICY

Name

FELIQS Inc.

Address

JLABS@NYC 101 6th Ave 3rd floor, New York, NY 10013, U.S.A

Capital

50,000,000 JPY

Main bank

MUFG bank

Pipeline

Feel free to write down your inquiry in the following form.

Please enter here to input your inquiries